| 发明名称 |
Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists |
| 摘要 |
Retinoids with retinoid receptor antagonistic activity, pharmaceutically acceptable salts and pharmaceutically acceptable hydrolyzable esters thereof, have been found efficacious in treating T-helper cell type 2 (Th2)-mediated immune diseases, such as immunoglobulin E (IgE)-mediated allergic diseases.
|
| 申请公布号 |
US2003176420(A1) |
申请公布日期 |
2003.09.18 |
| 申请号 |
US20030353523 |
申请日期 |
2003.01.29 |
| 申请人 |
|
发明人 |
BOLLAG WERNER;KLAUS MICHAEL;PANINA-BORDIGNON PAOLA;SINIGAGLIA FRANCESCO |
| 分类号 |
A61K9/06;A61K9/08;A61K9/107;A61K9/12;A61K9/14;A61K9/20;A61K9/48;A61K9/72;A61K31/166;A61K31/19;A61K31/192;A61K31/195;A61K31/196;A61K31/20;A61K31/201;A61K31/202;A61K31/216;A61K31/35;A61K31/352;A61K31/353;A61K31/38;A61K31/382;A61K31/385;A61K31/407;A61K31/415;A61K31/4162;A61K31/4184;A61K31/44;A61K31/4439;A61K31/55;A61K31/551;A61K31/5513;A61K45/00;A61P11/00;A61P11/02;A61P11/06;A61P17/00;A61P27/16;A61P29/00;A61P37/00;A61P37/06;A61P37/08;A61P43/00;C07C57/42;C07C57/48;C07D235/02;C07D243/38;C07D311/58;C07D335/06;C07D339/02;C07D401/06;C07D495/04;(IPC1-7):A61K31/551;A61K31/418 |
主分类号 |
A61K9/06 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
